Clinical Trial Update: NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update for neoadjuvant chemo-immunotherapy in pancreatic cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Australasian Gastro-Intestinal Trials Group | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING